Filing Details
- Accession Number:
- 0001319244-17-000010
- Form Type:
- 13G Filing
- Publication Date:
- 2017-01-25 16:18:28
- Filed By:
- Integrated Core Strategies (us) Llc
- Company:
- Achillion Pharmaceuticals Inc (NASDAQ:ACHN)
- Filing Date:
- 2017-01-25
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Integrated Core Strategies (US) | 0 | 1,529,719 | 0 | 1,529,719 | 1,529,719 | 1.1% |
ICS Opportunities, Ltd | 0 | 172,477 | 0 | 172,477 | 172,477 | 0.1% |
Integrated Assets, Ltd | 0 | 113,935 | 0 | 113,935 | 113,935 | 0.1% |
Millennium International Management | 0 | 286,412 | 0 | 286,412 | 286,412 | 0.2% |
Millennium International Management GP | 0 | 286,412 | 0 | 286,412 | 286,412 | 0.2% |
Millennium Management | 0 | 1,816,131 | 0 | 1,816,131 | 1,816,131 | 1.3% |
Israel A. Englander | 0 | 1,816,131 | 0 | 1,816,131 | 1,816,131 | 1.3% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
(AMENDMENT NO. 1)
ACHILLION PHARMACEUTICALS, INC. |
(Name of Issuer) |
COMMON STOCK, PAR VALUE $0.001 PER SHARE |
(Title of Class of Securities) |
00448Q201 |
(CUSIP Number) |
DECEMBER 31, 2016 |
(Date of event which requires filing of this statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
þ Rule 13d-1(c)
o Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 2 | of | 15 |
1 | NAMES OF REPORTING PERSONS Integrated Core Strategies (US) LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF
ORGANIZATION Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- | |
6 | SHARED VOTING POWER 1,529,719 | ||
7 | SOLE DISPOSITIVE POWER -0- | ||
8 | SHARED DISPOSITIVE
POWER 1,529,719 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 1,529,719 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 1.1% |
12 | TYPE OF REPORTING PERSON OO |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 3 | of | 15 |
1 | NAMES OF REPORTING PERSONS ICS Opportunities, Ltd. |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF
ORGANIZATION Cayman Islands |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- |
6 | SHARED VOTING POWER 172,477 | |
7 | SOLE DISPOSITIVE POWER -0- | |
8 | SHARED DISPOSITIVE POWER 172,477 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 172,477 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 0.1% |
12 | TYPE OF REPORTING PERSON CO |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 4 | of | 15 |
1 | NAMES OF REPORTING PERSONS Integrated Assets, Ltd. |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF
ORGANIZATION Cayman Islands |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- |
6 | SHARED VOTING POWER 113,935 | |
7 | SOLE DISPOSITIVE POWER -0- | |
8 | SHARED DISPOSITIVE POWER 113,935 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 113,935 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 0.1% |
12 | TYPE OF REPORTING PERSON CO |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 5 | of | 15 |
1 | NAMES OF REPORTING PERSONS Millennium International Management LP |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF
ORGANIZATION Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- |
6 | SHARED VOTING POWER 286,412 | |
7 | SOLE DISPOSITIVE POWER -0- | |
8 | SHARED DISPOSITIVE POWER 286,412 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 286,412 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 0.2% |
12 | TYPE OF REPORTING PERSON PN |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 6 | of | 15 |
1 | NAMES OF REPORTING PERSONS Millennium International Management GP LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF
ORGANIZATION Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- |
6 | SHARED VOTING POWER 286,412 | |
7 | SOLE DISPOSITIVE POWER -0- | |
8 | SHARED DISPOSITIVE POWER 286,412 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 286,412 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 0.2% |
12 | TYPE OF REPORTING PERSON OO |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 7 | of | 15 |
1 | NAMES OF REPORTING PERSONS Millennium Management LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF
ORGANIZATION Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- |
6 | SHARED VOTING POWER 1,816,131 | |
7 | SOLE DISPOSITIVE POWER -0- | |
8 | SHARED DISPOSITIVE POWER 1,816,131 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 1,816,131 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 1.3% |
12 | TYPE OF REPORTING PERSON OO |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 8 | of | 15 |
1 | NAMES OF REPORTING PERSONS Israel A. Englander |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) þ |
3 | SEC USE ONLY |
4 | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER -0- |
6 | SHARED VOTING POWER 1,816,131 | |
7 | SOLE DISPOSITIVE POWER -0- | |
8 | SHARED DISPOSITIVE POWER 1,816,131 |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 1,816,131 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES o |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9) 1.3% |
12 | TYPE OF REPORTING
PERSON IN |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 9 | of | 15 |
Item 1. | ||
| (a) | Name of Issuer: |
| ||
| Achillion Pharmaceuticals, Inc., a Delaware corporation (the "Issuer"). | |
| ||
| (b) | Address of Issuers Principal Executive Offices: |
| ||
| 300 George Street | |
Item 2. | (a) | Name of Person Filing: |
| (b) | Address of Principal Business Office: |
| (c) | Citizenship: |
| Integrated Core Strategies (US) LLC c/o Millennium Management LLC 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware | |
| ||
|
ICS Opportunities, Ltd. c/o Millennium International Management LP 666 Fifth Avenue New York, New York 10103 Citizenship: Cayman Islands | |
| ||
|
Integrated Assets, Ltd. c/o Millennium International Management LP 666 Fifth Avenue New York, New York 10103 Citizenship: Cayman Islands | |
| ||
| Millennium International Management LP 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware | |
| ||
| Millennium International Management GP LLC 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware | |
| ||
| Millennium Management
LLC 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware | |
| ||
| Israel A. Englander c/o Millennium Management LLC 666 Fifth Avenue New York, New York 10103 Citizenship: United States | |
| ||
(d) | Title of Class of Securities: | |
common stock, par value $0.001 per share ("Common Stock") | ||
| ||
(e) | CUSIP Number: | |
00448Q201 |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 10 | of | 15 |
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
| (a) | o | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |||
| (b) | o | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |||
| (c) | o | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |||
| (d) | o | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |||
| (e) | o | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) | o | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 11 | of | 15 |
| (g) | o | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | |||
| (h) | o | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |||
| (i) | o | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |||
| (j) | o | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount Beneficially Owned:
As of the close of business on January 24, 2017:
i) Integrated Core Strategies (US) LLC, a Delaware limited liability company ("Integrated Core Strategies"), beneficially owned 1,529,719 shares of the Issuers Common Stock;
ii) ICS Opportunities, Ltd., an exempted limited company organized under the laws of the Cayman Islands ("ICS Opportunities"), beneficially owned 172,477 shares of the Issuers Common Stock; and
iii) Integrated Assets, Ltd., an exempted limited company organized under the laws of the Cayman Islands ("Integrated Assets"), beneficially owned 113,935 shares of the Issuers Common Stock.
Millennium International Management LP, a Delaware limited partnership ("Millennium International Management"), is the investment manager to ICS Opportunities and Integrated Assets and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and Integrated Assets.
Millennium International Management GP LLC, a Delaware limited liability company ("Millennium International Management GP"), is the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and Integrated Assets.
Millennium Management LLC, a Delaware limited liability company ("Millennium Management"), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% shareholder of ICS Opportunities and Integrated Assets and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and Integrated Assets.
Israel A. Englander, a United States citizen ("Mr. Englander"), is the managing member of Millennium International Management GP and Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies, ICS Opportunities and Integrated Assets.
The foregoing should not be construed in and of itself as an admission by Millennium International Management, Millennium International Management GP, Millennium Management or Mr. Englander as to beneficial ownership of the securities owned by Integrated Core Strategies, ICS Opportunities or Integrated Assets, as the case may be.
(b) Percent of Class:
As of the close of business on January 24, 2017, Millennium Management and Mr. Englander may be deemed to have beneficially owned 1,816,131 shares or 1.3% of the Issuers Common Stock outstanding (see Item 4(a) above), which percentage was calculated based on 136,680,888 shares of Common Stock outstanding as of November 1, 2016, as per the Issuers Form 10-Q dated November 3, 2016.
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 12 | of | 15 |
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote-0-
(ii) Shared power to vote or to direct the vote
1,816,131 (See Item 4(b))
(iii) Sole power to dispose or to direct the disposition of
-0-
(iv) Shared power to dispose or to direct the disposition of
1,816,131 (See Item 4(b))
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group
See Exhibit I.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 13 | of | 15 |
Exhibits:
Exhibit I: Joint Filing Agreement, dated as of January 24, 2017, by and among Integrated Core Strategies (US) LLC, ICS Opportunities, Ltd., Integrated Assets, Ltd., Millennium International Management LP, Millennium International Management GP LLC, Millennium Management LLC and Israel A. Englander.
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 14 | of | 15 | ||||
SIGNATURE |
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
Dated: January 24, 2017
INTEGRATED CORE STRATEGIES (US) LLC
By: Integrated Holding Group LP,
its Managing Member
By: Millennium Management LLC,
its General Partner By: /s/ David NolanName: David Nolan
Title: Vice Chairman
ICS OPPORTUNITIES, LTD.
By: Millennium International Management LP,
its Investment ManagerBy: /s/ David NolanName: David Nolan
Title: Vice Chairman
INTEGRATED ASSETS, LTD.
By: Millennium International Management LP,
its Investment ManagerBy: /s/ David NolanName: David Nolan
Title: Vice Chairman
MILLENNIUM INTERNATIONAL MANAGEMENT LP
By: /s/David NolanName: David Nolan
Title: Vice Chairman
MILLENNIUM INTERNATIONAL MANAGEMENT GP LLC
By: /s/David NolanName: David Nolan
Title: Vice Chairman
MILLENNIUM MANAGEMENT LLC
By: /s/David NolanName: David Nolan
Title: Vice Chairman
/s/ Israel A. Englander by David Nolan
pursuant to Power of Attorney filed with
the SEC on June 6, 2005Israel A. Englander
CUSIP
No. | 00448Q201 | SCHEDULE 13G | Page | 15 | of | 15 | ||||
EXHIBIT I | ||||||||||
JOINT FILING AGREEMENT |
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Achillion Pharmaceuticals, Inc., a Delaware corporation, will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Dated: January 24, 2017
INTEGRATED CORE STRATEGIES (US) LLC
By: Integrated Holding Group LP,
its Managing Member
By: Millennium Management LLC,
its General Partner By: /s/ David NolanName: David Nolan
Title: Vice Chairman
ICS OPPORTUNITIES, LTD.
By: Millennium International Management LP,
its Investment ManagerBy: /s/ David NolanName: David Nolan
Title: Vice Chairman
INTEGRATED ASSETS, LTD.
By: Millennium International Management LP,
its Investment ManagerBy: /s/ David NolanName: David Nolan
Title: Vice Chairman
MILLENNIUM INTERNATIONAL MANAGEMENT LP
By: /s/David NolanName: David Nolan
Title: Vice Chairman
MILLENNIUM INTERNATIONAL MANAGEMENT GP LLC
By: /s/David NolanName: David Nolan
Title: Vice Chairman
MILLENNIUM MANAGEMENT LLC
By: /s/David NolanName: David Nolan
Title: Vice Chairman
/s/ Israel A. Englander by David Nolan
pursuant to Power of Attorney filed with
the SEC on June 6, 2005Israel A. Englander